Our findings highlight a novel mechanism of constant Notch3 signaling activation in NPC metastasis, and suggest IGF2BP3 as a potent prognostic biomarker and a potential target against progressive metastasis in NPC. Here, IGF2BP3 is linked to nasopharyngeal carcinoma.